Boill Healthcare Holdings Limited, an investment holding company, undertakes contracts for foundation piling in Hong Kong and Mainland China. More Details
Imperfect balance sheet and overvalued.
Share Price & News
How has Boill Healthcare Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 1246's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: 1246 underperformed the Hong Kong Construction industry which returned -18.3% over the past year.
Return vs Market: 1246 underperformed the Hong Kong Market which returned 0.7% over the past year.
Price Volatility Vs. Market
How volatile is Boill Healthcare Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall StCalculating The Fair Value Of Boill Healthcare Holdings Limited (HKG:1246)
3 months ago | Simply Wall StBoill Healthcare Holdings Limited (HKG:1246) Insiders Increased Their Holdings
4 months ago | Simply Wall StIs Boill Healthcare Holdings (HKG:1246) A Risky Investment?
Is Boill Healthcare Holdings undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: 1246 (HK$0.25) is trading above our estimate of fair value (HK$0.24)
Significantly Below Fair Value: 1246 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 1246 is unprofitable, so we can't compare its PE Ratio to the HK Construction industry average.
PE vs Market: 1246 is unprofitable, so we can't compare its PE Ratio to the Hong Kong market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 1246's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 1246 is good value based on its PB Ratio (0.6x) compared to the HK Construction industry average (0.9x).
How is Boill Healthcare Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Capital Goods industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Boill Healthcare Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Take a look at our analysis of 1246’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- Boill Healthcare Holdings competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Capital Goods industry.
How has Boill Healthcare Holdings performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 1246 is currently unprofitable.
Growing Profit Margin: 1246 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: 1246 is unprofitable, and losses have increased over the past 5 years at a rate of 9.4% per year.
Accelerating Growth: Unable to compare 1246's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 1246 is unprofitable, making it difficult to compare its past year earnings growth to the Construction industry (-5.6%).
Return on Equity
High ROE: 1246 has a negative Return on Equity (-25.04%), as it is currently unprofitable.
How is Boill Healthcare Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: 1246's short term assets (HK$212.2M) do not cover its short term liabilities (HK$1.1B).
Long Term Liabilities: 1246's short term assets (HK$212.2M) do not cover its long term liabilities (HK$216.0M).
Debt to Equity History and Analysis
Debt Level: 1246's debt to equity ratio (107.6%) is considered high.
Reducing Debt: 1246's debt to equity ratio has increased from 41.3% to 107.6% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 1246 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 1246 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 36.3% per year.
What is Boill Healthcare Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 1246's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 1246's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 1246's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 1246's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 1246's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Boill Healthcare Holdings has no CEO, or we have no data on them.
|Executive Chairman||3.08yrs||HK$600.00k||no data|
|Executive Director||3.08yrs||HK$120.00k||no data|
|Independent Non-Executive Director||2.83yrs||HK$120.00k||no data|
|Non-Executive Director||5.5yrs||HK$120.00k||no data|
|Independent Non-Executive Director||3.08yrs||HK$120.00k||no data|
|Independent Non-Executive Director||3.08yrs||HK$120.00k||no data|
Experienced Board: 1246's board of directors are considered experienced (3.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: 1246 insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Boill Healthcare Holdings Limited's company bio, employee growth, exchange listings and data sources
- Name: Boill Healthcare Holdings Limited
- Ticker: 1246
- Exchange: SEHK
- Industry: Construction and Engineering
- Sector: Capital Goods
- Market Cap: HK$226.850m
- Shares outstanding: 907.40m
- Website: https://www.boillhealthcare.com.hk
Number of Employees
- Boill Healthcare Holdings Limited
- Shun Tak Centre West Tower
- Unit 3704, 37th Floor
- Sheung Wan
- Hong Kong
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|1246||SEHK (The Stock Exchange of Hong Kong Ltd.)||Yes||Ordinary Shares||HK||HKD||Oct 2013|
|2945||SEHK (The Stock Exchange of Hong Kong Ltd.)||HKD0.25 (PARALLEL 22/10/20)||HK||HKD||Sep 2020|
Boill Healthcare Holdings Limited, an investment holding company, undertakes contracts for foundation piling in Hong Kong and Mainland China. It operates through Property Development, Healthcare Holiday Re ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/24 19:16|
|End of Day Share Price||2020/09/23 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.